Hims & Hers Health Inc’s recently made public that its Officer Melissa Baird acquired Company’s shares for reported $2.02 million on Jan 21 ’25. In the deal valued at $29.81 per share,67,687 shares were bought.
Then, Dudum Andrew bought 300 shares, generating $9,000 in total proceeds.
Before that, Boughton Soleil bought 54,153 shares. Hims & Hers Health Inc shares valued at $1,619,108 were divested by the Officer at a price of $29.90 per share.
Citigroup downgraded its Hims & Hers Health Inc [HIMS] rating to a Sell from a a Neutral in a research note published on January 10, 2025; the price target was increased to $25 from $24. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. Morgan Stanley began covering HIMS with “an Overweight” recommendation on December 17, 2024. BofA Securities revised its rating on November 14, 2024. It rated HIMS as “an Underperform” which previously was an “a Buy”.
Price Performance Review of HIMS
On Tuesday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock jump 7.04% to $29.81. Over the last five days, the stock has gained 15.10%. Hims & Hers Health Inc shares have risen nearly 23.28% since the year began. Nevertheless, the stocks have risen 254.04% over the past one year. While a 52-week high of $35.02 was reached on 01/21/25, a 52-week low of $8.14 was recorded on 01/10/25. SMA at 50 days reached $27.53, while 200 days put it at $20.28.
Levels Of Support And Resistance For HIMS Stock
The 24-hour chart illustrates a support level at 28.55, which if violated will result in even more drops to 27.28. On the upside, there is a resistance level at 30.54. A further resistance level may holdings at 31.26. The Relative Strength Index (RSI) on the 14-day chart is 59.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.93, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 3.20%. Stochastics %K at 85.43% indicates the stock is a selling.
How much short interest is there in Hims & Hers Health Inc?
A steep rise in short interest was recorded in Hims & Hers Health Inc stocks on 2024-12-31, growing by 9.5 million shares to a total of 52.12 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 42.62 million shares. There was a rise of 18.23%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 22, 2024 when Needham began covering the stock and recommended ‘”a Buy”‘ rating along with a $24 price target.
